Publications by authors named "Anne Angiolillo"

29Publications

Mercaptopurine Ingestion Habits, Red Cell Thioguanine Nucleotide Levels, and Relapse Risk in Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group Study AALL03N1.

J Clin Oncol 2017 May 24;35(15):1730-1736. Epub 2017 Mar 24.

Wendy Landier, Lindsey Hageman, Yanjun Chen, and Smita Bhatia, University of Alabama at Birmingham, Birmingham, AL; Nancy Kornegay, William E. Evans, and Mary V. Relling, St. Jude Children's Research Hospital, Memphis, TN; Bruce C. Bostrom, Children's Hospitals and Clinics of Minnesota, Minneapolis, MN; Jacqueline Casillas, David Geffen School of Medicine at University of California Los Angeles, Los Angeles; Leo Mascarenhas and Amanda M. Termuhlen, Children's Hospital Los Angeles, Los Angeles; F. Lennie Wong, City of Hope, Duarte, CA; David S. Dickens, Helen DeVos Children's Hospital at Spectrum Health/Spectrum Health at Butterworth Campus, Grand Rapids, MI; Anne L. Angiolillo, The George Washington School of Medicine, Washington, DC; Glen Lew, Children's Healthcare of Atlanta, Emory University, Atlanta, GA; Kelly W. Maloney, University of Colorado School of Medicine, Aurora, CO; A. Kim Ritchey, Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center, Pittsburgh, PA; and William L. Carroll, Perlmutter Cancer Center, New York University-Langone Medical Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.7579DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455766PMC
May 2017

Beyond CD19: Opportunities for Future Development of Targeted Immunotherapy in Pediatric Relapsed-Refractory Acute Leukemia.

Front Pediatr 2015 1;3:80. Epub 2015 Oct 1.

Hematologic Malignancies Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health , Bethesda, MD , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fped.2015.00080DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589648PMC
October 2015

Vincristine and Dactinomycin in Infantile Myofibromatosis With a Review of Treatment Options.

J Pediatr Hematol Oncol 2015 Apr;37(3):237-41

Departments of *Oncology ‡Pathology, Children's National Health System, Washington, DC †Department of Oncology, St Jude Children's Research Hospital, Memphis, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0000000000000286DOI Listing
April 2015

Pharmacokinetic and pharmacodynamic properties of calaspargase pegol Escherichia coli L-asparaginase in the treatment of patients with acute lymphoblastic leukemia: results from Children's Oncology Group Study AALL07P4.

J Clin Oncol 2014 Dec 27;32(34):3874-82. Epub 2014 Oct 27.

Anne L. Angiolillo, Reuven J. Schore, Ashley R. Lane, and Gregory H. Reaman, Children's National Medical Center, Washington, DC; Meenakshi Devidas, Colleges of Medicine, Public Health and Health Professions, University of Florida; Charlotte Wood and Hao W. Zheng, Children's Oncology Group, Gainesville, FL; Michael J. Borowitz, Johns Hopkins Medical Institutions, Baltimore; Taha Keilani, Sigma-Tau Pharmaceuticals, Gaithersburg, MD; Andrew J. Carroll, University of Alabama at Birmingham, Birmingham, AL; Julie M. Gastier-Foster and Nyla A. Heerema, Ohio State University Wexner Medical Center; Julie M. Gastier-Foster, Ohio State University College of Medicine and Nationwide Children's Hospital, Columbus, OH; Mignon L. Loh, University of California at San Francisco, San Francisco, CA; Peter C. Adamson, Children's Hospital of Philadelphia, Philadelphia, PA; Brent Wood, University of Washington, Seattle, WA; Elizabeth A. Raetz and William L. Carroll, New York University Cancer Institute, New York University Langone Medical Center, New York, NY; Naomi J. Winick, University of Texas Southwestern Medical Center, Dallas, TX; and Stephen P. Hunger, Children's Hospital Colorado and University of Colorado School of Medicine, Aurora, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.5763DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239306PMC
December 2014

Informed consent for pediatric phase 1 cancer trials: physicians' perspectives.

Cancer 2010 Jul;116(13):3244-50

Department of Pediatric Hematology/Oncology, Children's Hospital, Cleveland Clinic, Cleveland, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25158DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2892009PMC
July 2010

A phase II study of Campath-1H in children with relapsed or refractory acute lymphoblastic leukemia: a Children's Oncology Group report.

Pediatr Blood Cancer 2009 Dec;53(6):978-83

Division of Oncology, Children's National Medical Center, Washington, District of Columbia 20010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.22209DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120889PMC
December 2009

Phase 1 and pharmacokinetic study of concurrent carboplatin and irinotecan in subjects aged 1 to 21 years with refractory solid tumors.

Cancer 2009 Jan;115(1):207-16

Department of Pediatric Hematology/Oncology, Children's Hospital at Montefiore/Albert Einstein College of Medicine, Bronx, New York 10467, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.23992DOI Listing
January 2009

A phase I study of 90yttrium-ibritumomab-tiuxetan in children and adolescents with relapsed/refractory CD20-positive non-Hodgkin's lymphoma: a Children's Oncology Group study.

Clin Cancer Res 2007 Sep;13(18 Pt 2):5652s-5660s

Division of Pediatric Heamtology and Blood and Marrow Transplantation, Medicine and Pathology, Columbia University, New York, New York 10032, and Children's Hospital of Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-07-1060DOI Listing
September 2007

A survey of language barriers from the perspective of pediatric oncologists, interpreters, and parents.

Pediatr Blood Cancer 2006 Nov;47(6):819-24

Department of Anthropology, Case Western Reserve University, Cleveland, OH 44106-4976, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.20841DOI Listing
November 2006

How low is too low? Use of cluster analysis to define low levels of mercaptopurine metabolites.

Pediatr Blood Cancer 2006 Feb;46(2):187-92

Department of Bioethics, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.20518DOI Listing
February 2006

Phase II study of gemcitabine in children with relapsed acute lymphoblastic leukemia or acute myelogenous leukemia (ADVL0022): a Children's Oncology Group Report.

Pediatr Blood Cancer 2006 Feb;46(2):193-7

Children's National Medical Center, George Washington University, Washington, DC, District of Columbia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.20419DOI Listing
February 2006

Hemolysis following an out-of-group platelet transfusion in an 8-month-old with Langerhans cell histiocytosis.

J Pediatr Hematol Oncol 2004 Apr;26(4):267-9

George Washington University School of Medicine and Children's National Medical Center, Washington, DC 20010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00043426-200404000-00012DOI Listing
April 2004

Communication of randomization in childhood leukemia trials.

JAMA 2004 Jan;291(4):470-5

Rainbow Center for Pediatric Ethics, Department of Pediatrics, Rainbow Babies and Children's Hospital, University Hospitals of Cleveland, Cleveland, Ohio 44106, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.291.4.470DOI Listing
January 2004